Matches in SemOpenAlex for { <https://semopenalex.org/work/W2004293616> ?p ?o ?g. }
- W2004293616 endingPage "106" @default.
- W2004293616 startingPage "96" @default.
- W2004293616 abstract "Recent advances in understanding the importance of angiogenesis to tumor growth and distant metastasis has driven the development of antiangiogenic therapies for the treatment of non–small-cell lung cancer (NSCLC). The anti–vascular endothelial growth factor (VEGF) monoclonal antibody, bevacizumab, is the only US Food and Drug Administration–approved antiangiogenic agent for advanced NSCLC. Accumulated safety data with bevacizumab in NSCLC shows that patients are at risk for hemorrhage, venous thromboembolism, hypertension, and proteinuria. Investigational agents that target VEGF via a different mechanism (such as aflibercept [VEGF Trap]) or simultaneously inhibit multiple molecular pathways involved in angiogenesis (ie, multitargeted tyrosine kinase inhibitors [TKIs]) and vascular disrupting agents (VDAs) that target existing tumor vasculature are in various stages of clinical development for NSCLC, and safety profiles are emerging for these classes of agents. This review describes the molecular rationale for targeting angiogenic pathways in anticancer therapy and summarizes safety and tolerability data from clinical trials of bevacizumab or aflibercept in combination with chemotherapy and the investigational TKIs and VDAs in patients who have advanced NSCLC." @default.
- W2004293616 created "2016-06-24" @default.
- W2004293616 creator A5025836672 @default.
- W2004293616 date "2012-03-01" @default.
- W2004293616 modified "2023-09-25" @default.
- W2004293616 title "Safety Profile and Tolerability of Antiangiogenic Agents in Non–Small-Cell Lung Cancer" @default.
- W2004293616 cites W1918989451 @default.
- W2004293616 cites W1963669837 @default.
- W2004293616 cites W1965024282 @default.
- W2004293616 cites W1965727465 @default.
- W2004293616 cites W1967587727 @default.
- W2004293616 cites W1977999028 @default.
- W2004293616 cites W1985804036 @default.
- W2004293616 cites W1986092295 @default.
- W2004293616 cites W1986716191 @default.
- W2004293616 cites W1989031892 @default.
- W2004293616 cites W1989109072 @default.
- W2004293616 cites W1993016882 @default.
- W2004293616 cites W2005054196 @default.
- W2004293616 cites W2008552099 @default.
- W2004293616 cites W2012460154 @default.
- W2004293616 cites W2014075906 @default.
- W2004293616 cites W2031859764 @default.
- W2004293616 cites W2035627783 @default.
- W2004293616 cites W2040289964 @default.
- W2004293616 cites W2048596392 @default.
- W2004293616 cites W2051201686 @default.
- W2004293616 cites W2056242981 @default.
- W2004293616 cites W2074238578 @default.
- W2004293616 cites W2076017354 @default.
- W2004293616 cites W2089756110 @default.
- W2004293616 cites W2092323746 @default.
- W2004293616 cites W2093116780 @default.
- W2004293616 cites W2095729959 @default.
- W2004293616 cites W2096134439 @default.
- W2004293616 cites W2100785570 @default.
- W2004293616 cites W2101247829 @default.
- W2004293616 cites W2102996502 @default.
- W2004293616 cites W2105246037 @default.
- W2004293616 cites W2105677187 @default.
- W2004293616 cites W2108923852 @default.
- W2004293616 cites W2109240520 @default.
- W2004293616 cites W2111512928 @default.
- W2004293616 cites W2112768035 @default.
- W2004293616 cites W2112940666 @default.
- W2004293616 cites W2115330744 @default.
- W2004293616 cites W2116665727 @default.
- W2004293616 cites W2116991471 @default.
- W2004293616 cites W2125212831 @default.
- W2004293616 cites W2126310082 @default.
- W2004293616 cites W2127045236 @default.
- W2004293616 cites W2131705241 @default.
- W2004293616 cites W2132000516 @default.
- W2004293616 cites W2139675556 @default.
- W2004293616 cites W2140765540 @default.
- W2004293616 cites W2141236760 @default.
- W2004293616 cites W2144660856 @default.
- W2004293616 cites W2145835533 @default.
- W2004293616 cites W2146147508 @default.
- W2004293616 cites W2151229627 @default.
- W2004293616 cites W2154581953 @default.
- W2004293616 cites W2155912767 @default.
- W2004293616 cites W2158734599 @default.
- W2004293616 cites W2159370421 @default.
- W2004293616 cites W2159711942 @default.
- W2004293616 cites W2167798736 @default.
- W2004293616 cites W2168258970 @default.
- W2004293616 cites W2169976781 @default.
- W2004293616 cites W2229860909 @default.
- W2004293616 cites W2261037082 @default.
- W2004293616 cites W2267882175 @default.
- W2004293616 cites W2276604843 @default.
- W2004293616 cites W2339460051 @default.
- W2004293616 cites W2403815535 @default.
- W2004293616 cites W2540110531 @default.
- W2004293616 cites W2602204204 @default.
- W2004293616 cites W4245635197 @default.
- W2004293616 cites W4253705647 @default.
- W2004293616 doi "https://doi.org/10.1016/j.cllc.2011.08.006" @default.
- W2004293616 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22056889" @default.
- W2004293616 hasPublicationYear "2012" @default.
- W2004293616 type Work @default.
- W2004293616 sameAs 2004293616 @default.
- W2004293616 citedByCount "15" @default.
- W2004293616 countsByYear W20042936162012 @default.
- W2004293616 countsByYear W20042936162013 @default.
- W2004293616 countsByYear W20042936162014 @default.
- W2004293616 countsByYear W20042936162016 @default.
- W2004293616 countsByYear W20042936162018 @default.
- W2004293616 countsByYear W20042936162020 @default.
- W2004293616 countsByYear W20042936162022 @default.
- W2004293616 countsByYear W20042936162023 @default.
- W2004293616 crossrefType "journal-article" @default.
- W2004293616 hasAuthorship W2004293616A5025836672 @default.
- W2004293616 hasConcept C121608353 @default.
- W2004293616 hasConcept C126322002 @default.
- W2004293616 hasConcept C143998085 @default.
- W2004293616 hasConcept C167734588 @default.